녹십자수의약품 주식회사

{
  "address": "충청남도 예산군",
  "ceo_name": "나승식",
  "certificate": [
    {
      "cert_number": "20190300320",
      "changes": "",
      "disclosure_date": "2019-04-11",
      "first_cert_date": "2019-04-11",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2019-04-11 ~ 2021-04-10"
    },
    {
      "cert_number": "20210421010046",
      "changes": "",
      "disclosure_date": "2021-04-21",
      "first_cert_date": "2019-04-11",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2021-04-11 ~ 2024-04-10"
    },
    {
      "cert_number": "20240425010008",
      "changes": "",
      "disclosure_date": "2024-04-25",
      "first_cert_date": "2019-04-11",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2024-04-11 ~ 2027-04-10"
    }
  ],
  "company_name": "녹십자수의약품  주식회사",
  "corp_no": "164911-*******",
  "financials": {
    "2022": {
      "capital_stock": 12037344000,
      "cost_of_sales": 19071777000,
      "current_assets": 26134974000,
      "current_liabilities": 15125246000,
      "gross_profit": 7749914000,
      "net_income": 648558000,
      "net_income_bs": 648558000,
      "non_current_assets": 32241801000,
      "non_current_liabilities": 8408779000,
      "non_operating_expenses": 1432085000,
      "non_operating_income": 1539293000,
      "operating_profit": 541350000,
      "revenue": 26821691000,
      "sga_expenses": 7208564000,
      "total_assets": 58376775000,
      "total_equity": 34842750000,
      "total_liabilities": 23534025000
    },
    "2023": {
      "capital_stock": 12255186000,
      "cost_of_sales": 21151755000,
      "current_assets": 24315749000,
      "current_liabilities": 13528067000,
      "gross_profit": 8013765000,
      "net_income": 81109000,
      "net_income_bs": 81109000,
      "non_current_assets": 34979567000,
      "non_current_liabilities": 10581296000,
      "non_operating_expenses": 1581592000,
      "non_operating_income": 2024549000,
      "operating_profit": -361848000,
      "revenue": 29165520000,
      "sga_expenses": 8375613000,
      "total_assets": 59295316000,
      "total_equity": 35185953000,
      "total_liabilities": 24109363000
    },
    "2024": {
      "capital_stock": 12302795000,
      "cost_of_sales": 24640915000,
      "current_assets": 24127139000,
      "current_liabilities": 16205716000,
      "gross_profit": 9120959000,
      "net_income": -2091119000,
      "net_income_bs": -2091119000,
      "non_current_assets": 35782512000,
      "non_current_liabilities": 7700502000,
      "non_operating_expenses": 2548243000,
      "non_operating_income": 918774000,
      "operating_profit": -461650000,
      "revenue": 33761874000,
      "sga_expenses": 9582609000,
      "total_assets": 59909651000,
      "total_equity": 36003433000,
      "total_liabilities": 23906218000
    }
  },
  "industry": "동물용 의약품 제조업",
  "investment": [
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2019-01-25"
    },
    {
      "amount": "500,000,000",
      "changes": "500,000,000",
      "date": "2019-01-25"
    },
    {
      "amount": "999,999,990",
      "changes": "999,999,990",
      "date": "2019-01-25"
    },
    {
      "amount": "499,999,310",
      "changes": "499,999,310",
      "date": "2019-01-25"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2019-01-23"
    }
  ],
  "main_products": "동물용의약품(PED-M)",
  "phone": "031-323-****",
  "years": [
    2024,
    2023,
    2022
  ]
}